COVID Testing Machine: How to Choose the Right System for Your Lab

A laboratory expecting 24 respiratory specimens in one morning needs more than a machine with an attractive run-time figure: it needs a workable plan for batching, staffing and reporting. Choosing a covid testing machine around that whole workflow helps labs and distributors compare systems on what they can deliver in practice.

A COVID testing machine is an instrument used with a specified assay to detect SARS-CoV-2. Choose by matching the method—such as RT-PCR, another molecular approach or antigen testing—to your intended use, then compare the complete workflow, reportable capacity, consumable costs, documentation and support. A suitable system is one your team can operate reliably within its actual specimen and reporting process.

What a COVID testing machine includes

The phrase can describe several different products: a real-time PCR instrument, a compact molecular system with a dedicated assay, or a reader used with rapid antigen tests. These systems use different methods and workflows, so their results, operating requirements and intended settings are not interchangeable.

For procurement, treat the system as a connected set of components rather than a standalone instrument. A typical molecular workflow involves a collection device, specimen transport, preparation, assay reagents, an instrument, controls, software and result review. A quotation for the instrument alone may leave out recurring costs and tasks that determine whether the system fits your laboratory.

Start by recording what you need the system to do. Include the types of samples you expect, when they arrive, how quickly an authorised result is needed, who will run tests and how results enter your reporting process. For example, a clinic receiving small numbers of samples throughout the day may value flexible testing more than a high maximum batch size.

Compare test methods and instrument formats

The method determines what the instrument measures and what the operator must do. RT-PCR amplifies targeted genetic material. Antigen tests detect viral proteins and may use a simpler workflow. Some molecular platforms use amplification methods other than conventional thermal cycling; the word “rapid” alone does not identify the technology.

Mylab’s January 2022 CoviSwift announcement described a system comprising its assay and Compact-Q instrument, with a stated capacity of 16 samples in 40 minutes from swab to report. That is a historical, product-specific company claim—not a general capacity figure for compact molecular systems. It illustrates why a buyer should assess the stated workflow and its conditions alongside the instrument name.

The table distinguishes broad formats, not performance rankings. For each candidate, ask for the current instructions for use and a demonstration of the exact assay being offered. Compare sample type, preparation, controls, result interpretation and reporting—not just the machine’s size or the “rapid” label.

Turn daily demand into practical throughput

Throughput is the number of samples a system can process over a defined period. Turnaround is the elapsed time to a result under stated conditions. A short instrument run does not necessarily mean a short specimen-to-report process: receipt, preparation, loading, review and reporting also take time.

Use a worked planning example rather than multiplying a brochure run time into a full day’s output. Suppose a hypothetical system runs eight samples in 45 minutes, with 15 minutes for setup and loading and 15 minutes for review and resetting. One complete cycle takes 75 minutes. Two cycles could process 16 samples in 150 minutes before accounting for breaks, failed controls, repeats or interruptions. These are planning assumptions, not a claim about a product’s performance.

Now apply the example to the lab expecting 24 specimens in a morning. The two-cycle plan leaves eight specimens for another cycle or a later run, so the team should decide whether that delay is acceptable, whether smaller batches are possible, or whether the workload calls for a different capacity. The useful comparison is completed, reviewed results within the required window—not the maximum number of wells or tubes listed in a brochure.

Record these figures for each system under consideration:

• Samples per run and whether controls occupy positions in that capacity.
• Instrument run time and the separate preparation and review time.
• Expected daily volume, peak arrival window and staffing available during that window.
• How repeats, invalid results and planned downtime affect the schedule.

This simple schedule makes a bottleneck visible. If one trained operator must prepare specimens and approve results, adding instrument capacity may not increase the number of reports released on time.

Calculate cost per reportable result

Compare the cost of a reportable result, not just the purchase price or cost per test kit. Include consumables, controls, staff time, service and the instrument’s annual cost. Divide the total operating cost for the same period by the number of results the lab expects to release in that period.

Here is a hypothetical annual worksheet for a small service. Assume 1,000 reportable results, consumables at ₹240 per attempted test, an allowance of 5% additional attempts, controls costing ₹30 per reportable result, labour at ₹50 per result, and annualised instrument and service costs of ₹180,000. The consumable allowance is ₹252 per reportable result (₹240 × 1.05); adding ₹30, ₹50 and ₹180 gives an estimated ₹512 per reportable result. These are example inputs for showing the calculation, not market prices or a supplier quotation.

The result changes when the volume or assumptions change. If the same annual equipment and service cost is spread across 2,000 results, that portion falls from ₹180 to ₹90 per result. If consumables are sold only in large packs and the lab uses a small fraction before expiry, actual costs may move in the other direction. Ask for pack sizes and include expected wastage in the worksheet.

Use this formula in a tender comparison: (annual instrument and service cost + annual consumables + controls + labour) ÷ annual reportable results. Keep the assumptions visible in separate columns. This lets a hospital compare two systems without confusing a low kit price with a low operating cost.

Plan specimen collection, transport and receiving

The instrument cannot make up for a specimen that does not meet the assay’s collection and handling instructions. Before purchase, identify the acceptable swab, transport medium, specimen volume, temperature conditions and time limits for the specific assay. These details belong in the laboratory’s collection and receiving procedure, not in assumptions carried over from another kit.

Map the route from collection site to analyser. A specimen collected at an outreach clinic may pass through packaging, transport and accessioning before testing. Define who labels it, what information accompanies it, how staff identify a damaged or unsuitable sample, and where it waits before preparation. A short receiving checklist can reduce avoidable delays at the bench.

We manufacture viral transport media at our plant in Okhla, New Delhi, alongside IVD rapid tests and urine reagent strips. VTM is one part of specimen transport; it is not a substitute for checking whether a selected assay accepts that medium. In product discussions, distributors and laboratories need clear answers about product documentation, pack formats and the intended workflow. We connect those questions to the assay’s own instructions rather than treating one transport product as universal.

If you are reviewing collection and transport supplies alongside equipment, see our IVD product range and product downloads. Share the assay and specimen workflow when assessing compatibility so the right product information can be considered for the intended use.

Match the system to staff, space and service

A compact footprint can help when bench space is limited, but equipment still needs an appropriate operating area and safe specimen handling. Compare each candidate’s documented environmental and electrical requirements with the intended site. Also map clean and potentially contaminated work, storage locations and the path used for biological waste.

List operator tasks from sample receipt to authorised result. The supplier demonstration should show the actual steps for loading a sample, handling controls, reviewing results and responding to an invalid run. Have the staff who will use the system perform the workflow; a presentation by a sales representative will not show where your team needs additional training.

Service and continuity affect routine capacity. Record who provides training, troubleshooting and maintenance in your territory, and what happens when the instrument is unavailable. For a distributor or importer, include escalation contacts and a plan for consumable replenishment. A system that fits the bench but has no workable support route can become a bottleneck during a busy reporting period.

Review documents and supply terms before ordering

Tie the instrument to the exact assay and intended use being purchased. Review the current instructions for use, sample types, performance information and regulatory documents applicable to the market where the system will be supplied. Record the document versions and product identifiers in the purchasing file so the lab can match incoming kits to the approved workflow.

For a quotation, request the instrument configuration, assay pack sizes, controls, software, training, warranty, service terms and consumables needed for routine operation. Ask how product changes and updated instructions are communicated. Availability, price and local authorisation are product- and market-specific, so the buying decision should use current written terms from the manufacturer or authorised supplier rather than a launch announcement.

For territory distribution or private-label discussions, separate commercial arrangements from technical and regulatory responsibilities. Define who supplies customer training, technical support, product documentation and post-sale service. A distributor’s ability to supply a product does not remove the need for the laboratory or local business to establish that the test is suitable and permitted for its intended use.

Use this short request-for-quotation checklist:

1. Assay method, intended use, sample types and current instructions.
2. Capacity per run, controls occupying positions and steps included in stated turnaround.
3. Required preparation equipment, consumables, pack sizes and software.
4. Training, maintenance, warranty and local service arrangements.
5. Regulatory documentation, supply terms and notification of product changes.

Choose by workload, not by the headline claim

A small clinic, a hospital laboratory and a distributor may all evaluate a COVID testing machine, but their decision criteria differ. The clinic may prioritise a manageable workflow for intermittent specimens. A hospital may focus on peak-volume scheduling, backup processes and integration into result review. A distributor may need a clear supply and support model across several customer types.

Make a shortlist of two or three systems and score each against the same requirements. A useful comparison gives greater weight to the needs that can disrupt service: acceptable specimen workflow, reportable capacity during peak periods, operator workload, full cost per result and support access. Use the same sample-volume scenario and cost assumptions for every quote.

Before committing, have the intended operators walk through the complete process and record the time and equipment required at each stage. Confirm that the required consumables and documentation fit the lab’s operating plan. This turns a product comparison into a practical decision about whether the system can produce the results your service needs, when they are needed.

FAQ

When should a lab switch from antigen testing to molecular testing?

Consider a change when the current testing pathway no longer meets the lab’s intended use, reporting needs or documented requirements. Compare the assays’ permitted uses, specimen workflow, staffing and total cost, then agree how results will be reported. A change in method also requires updated procedures and staff training before routine use.

What should staff do when a COVID test result is invalid?

Follow the specific assay instructions for the invalid result and control outcome; do not apply a response from another kit. The lab’s procedure should identify who reviews the run, whether a repeat is permitted, how a new specimen is handled if needed, and how the event is recorded. Include this scenario in the supplier demonstration and staff training.

How should a distributor compare two systems for different customer sites?

Compare each system against distinct site profiles instead of choosing one headline capacity for every customer. A clinic with intermittent specimens and a hospital with morning peaks may need different batch flexibility and support. For each profile, model sample volume, operator availability, consumable supply, service coverage and the documentation required in that market.

What should a lab do if specimen transport conditions are disrupted?

Keep affected specimens separate from routine processing and follow the assay’s handling instructions and the laboratory’s rejection or escalation procedure. Record the collection and transport details available, then determine whether the sample remains suitable for testing. Do not substitute a different transport medium or storage condition without support from the assay’s documented requirements.